Catalyst Wire Dossier Catalyst Wire Dossier
EMA label_change · 2017-06-23

EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome

View source ↗

Summary

EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome, indicating ongoing authorization status and review outcome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbioflor 2